SAN DIEGO--(BUSINESS WIRE)--NexMed, Inc. (Nasdaq: NEXMD), a specialty CRO with a pipeline of products based on the NexACT® technology, today announced that Deirdre Y. Gillespie, M.D., President and Chief Executive Officer of publicly-held La Jolla Pharmaceutical Company, has been appointed to the Company’s Board of Directors, effective immediately.
